Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
10.1056/NEJMoa020681
Saved in:
Main Authors: | Marcellin, P., Chang, T.-T., Lim, S.G., Tong, M.J., Sievert, W., Shiffman, M.L., Jeffers, L., Goodman, Z., Wulfsohn, M.S., Xiong, S., Fry, J., Brosgart, C.L. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/117545 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
by: Hadziyannis, S.J., et al.
Published: (2014) -
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
by: Marcellin, P., et al.
Published: (2016) -
Clinical trial: Effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011) -
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
by: Hadziyannis, S.J., et al.
Published: (2011) -
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant
by: Wai, C.-T., et al.
Published: (2012)